Teva says Humana can't rely on limited agreement with US DOJ in generic drug case
MLex Summary: Teva Pharmaceuticals filed an opposition to Humana’s motion for judgment in a US antitrust case over generic drug prices, arguing that it can’t rely on Teva’s deferred prosecution agreement...To view the full article, register now.
Already a subscriber? Click here to view full article